Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2007

View Archived Issues

Emisphere reports data on oral delivery of GLP-1 and PYY

Alpharma licenses novel technology from Tris Pharma

Enzon studies HIF-1 alpha antagonist in phase I trial

Safety and pharmacokinetics established for XTL-6865 in HCV

MedImmune licenses reverse genetics intellectual property to sanofi pasteur

VioQuest adds two new products to pipeline

Athersys achieves commercial collaboration milestones

Pivotal study of romidepsin in CTCL cleared to continue

Takeda acquires rights to R-851 from 3M

Galapagos achieves milestones in GSK osteoarthritis collaboration

Development of Pevion's malaria vaccine supported by E.U. grant

Phase II study of LE-SN38 misses primary tumor response endpoint

Topical interferon alpha-2b shows clinically efficacious response in LSIL

Berlex reports on novel CCR5 antagonists

Recent patents impart new therapeutic agents for cancer

IND clearance sought for phase II ophthalmic study of Tbeta4 eye drops

Parkinson's disease drug pergolide withdrawn

EMEA recommends restrictions on use of Ketek

Lutetium-177-labeled monoclonal antibody cG250 appears safe in renal cell carcinoma

V-HeFT I and II formulations of isosorbide dinitrate/hydralazine not bioequivalent

Nicotine patch appears safe for use in coronary artery disease patients

Novel KCNQ2 channel opener shows antiepileptic activity in mice

Novel treatment options for inflammatory disorders claimed in recent GSK and Palau patents

Novel therapeutic agents for immunological disorders disclosed in recent patents

Cardiome Pharma updates status of key programs

Lucentis launched in the U.K.

Transition receives fast track designation for Alzheimer's disease drug candidate

Santen seeks European approval of tafluprost

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...